
The research team used AI tools to discover controllable regulatory factors to guide cancer cells into a less aggressive state
AI-generated summary
Glioblastoma is one of the deadliest brain cancers, in part because its cancer cells are able to change their own cellular properties to survive treatment. A study jointly conducted by Germany and the United Kingdom found that the changes in these cancer cells follow predictable and hidden patterns. The study was published in the journal Nature.
Glioblastoma is one of the deadliest brain cancers, in part because its cancer cells are able to change their own cellular properties to survive treatment. A study conducted jointly by Germany and the United Kingdom found that the changes in these cancer cells follow predictable and hidden patterns. The research was published in the journal Nature.
According to the science website SciTechDaily, a research team from the German Cancer Research Center and the Wellcome Sanger Institute in the UK plans to start research on glioblastoma "from scratch." The researchers put forward an idea: Can they assume that they know nothing about the disease and reconstruct the behavior pattern of cancer cells through quantitative analysis?
After having the idea, the research team analyzed the DNA, RNA and epigenetic information from the tumors of 12 glioblastoma patients, and established one of the most comprehensive molecular maps of glioblastoma currently. After analyzing the map, the researchers found that cancer cells follow specific molecular rules to switch between different cell states.
The analysis showed that some cancer cells exhibit neuron-like characteristics, others have stem cell properties, and some transform into a highly invasive state similar to a tissue damage response. This ability of cells to adapt and transform is called "Cellular Plasticity" and is also an important reason why tumors develop treatment resistance.
The research team also noticed that cancer cells in different states were also distributed in specific areas within the tumor. The researchers further confirmed this distribution pattern using laboratory-grown tumor organoids.
After discovering the hidden patterns of change, the research team then analyzed the gene regulation mechanisms in more than 1 million cancer cells taken from glioblastoma patients. The researchers used a deep learning tool called "scDORI" to identify the molecular regulators that affect the state transition of cancer cells. Some of these regulatory factors act like protective mechanisms, keeping cancer cells in a relatively stable state and limiting their cellular plasticity.
The analysis showed that by regulating a few key regulatory factors, it is possible to guide cancer cells into a less aggressive state. When the researchers increased the activity of the regulatory factor MYT1L, the cell plasticity and malignant characteristics of cancer cells were reduced.
The research team said that the team had long hypothesized that understanding the rules behind glioblastoma cells would allow them to not only observe what the cancer cells are doing, but also further modify their behavior. And experiments have indeed proven that only a few regulatory factors need to be manipulated to guide cancer cells to transform into a specific cell state.
The research team pointed out that through cell atlas and new artificial intelligence tools, the team found new regulatory sequences, which may in the future induce glioblastoma cells to transform into specific states in specific tumor environments. The researchers added that although this experiment is of far-reaching significance, there is still some way to go before it can be used in actual clinical treatment.
AI outlook — possibilities, not facts
The research team will further verify the feasibility of manipulating regulatory factors in clinical treatment
Possible · Within months

Chen Baihong, director of the Rehabilitation Department of Kuok General Hospital, pointed out that frozen shoulder (adhesive capsulitis) will not be cured by waiting. Some patients have residual symptoms for more than 10 years. When first-line drugs and rehabilitation are ineffective, ultrasound-guided capsuloplasty can be considered. The procedure takes about 10 minutes and can be completed in an outpatient clinic, but it must be combined with follow-up rehabilitation to completely solve the problem.

The groundbreaking ceremony for the new medical building at the Xindian campus of Catholic Tien Xin Hospital was held on November 10, 2026. New Taipei City Mayor Hou Youyi and New Taipei City mayoral candidates Su Qiaohui and Li Sichuan attended the ceremony. The new building is planned to have 14 floors above ground and 4 floors underground. It will integrate four specialist centers for diabetes, urology, chest and heart, and introduce smart nursing stations, mobile medical services and AI-assisted diagnosis and treatment. The project will cost approximately 6 billion yuan, and the city government will help speed up the administrative process.

The influenza epidemic has cooled down for several consecutive weeks, but the number of severe cases of influenza still exceeded 100 last week. The CDC has not yet announced that it is out of the epidemic period. It will be observed for another two weeks and the conditions for use of antiviral drugs will be extended for the third time to November 30.

The emergency department at National Taiwan University Hospital is likely to be overcrowded for more than 100 days this year, far exceeding last year's 88 days. During the Mid-Autumn Festival holiday, there were 430 emergency patients, a record high. The hospital plans to add 20 emergency observation beds and integrated medical and surgical inpatient wards, and the National Health Insurance Department is also planning a pilot project for special temporary benefits for emergency patients.

The U.S. FDA requires GLP-1 weight loss and diabetes drugs such as Trixan and Mengena to add warnings on the package labels, reminding them that they may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), which may lead to sudden vision loss or even permanent damage. Eli Lilly and Novo Nordisk responded respectively. Citi analysts believe that concerns may be deepened in the short term, but the impact on prescriptions will be limited.

Baylor College of Medicine, Houston Methodist Hospital and other institutions analyzed data from nearly 3.495 million American men and found that erectile dysfunction is associated with a higher risk of cardiovascular disease. The risk ratio for men aged 41 to 50 was 2.54, but retrospective studies cannot prove causality.